Risk factor | Number of patients in PICC group (nā=ā20) | Number of patients in LTSTC group (nā=ā4) |
---|---|---|
Known background of inherited prothrombotic conditions (%) | 0 (0) | 0 (0) |
History of VTE or PE (%) | 2 (10) | 0 (0) |
Chemotherapy administered (%): | Ā | Ā |
āāĀ Immunomodulatory drug | 2 (10) | 2 (10) |
āāĀ Hormonal therapy | 0 (0) | 0 (0) |
Anti-platelet therapy (%) | 0 (0) | 0 (0) |
Anti-coagulant prophylaxis (LMWH) (%) | 2 (10) | 2 (10) |